Industry News
Haplomic Technologies nabs EU, US patents
Haplomic Technologies has picked up patents in the EU and the US for its core IP, which covers genetic sequencing technologies based on haplotypes. [ + ]
US excipients market forecast to rise
US research firm The Freedonia Group has released the report 'Excipients', an industry study showcasing trends and forecasts in the pharmaceutical excipients market. The study also analyses market environment factors, evaluates company market share and profiles 47 US industry competitors. [ + ]
New genes found on Y chromosomes
A comparison of Y chromosome sequences across various mammals has revealed new gene repertoires for the major groups. [ + ]
Cell Therapies names new CEO
Cell Therapies has selected Dr Tim Oldham to become its new CEO to help drive the company's South-East Asian growth strategy. [ + ]
Successful antibody screening study
Therapeutic antibody supplier MorphoSys and technology company Biametrics will continue their collaboration in the area of high-throughput antibody screening following a successful feasibility study. [ + ]
Phosphagenics completes enrolment in acne trial
Phosphagenics has completed enrolment for a phase II trial of an acne treatment candidate that uses its TPM transdermal drug delivery technology. [ + ]
UNSW physicist joins elite US academy
Scientia Professor of Physics Michelle Simmons, from the University of New South Wales (UNSW), has been elected as a foreign honorary member of the American Academy of Arts and Sciences. She is one of only 10 Australians to have received such an honour. [ + ]
Export study reveals barriers for Australian companies
The most comprehensive export survey of its type, Australia's International Business Survey, was conducted to understand and highlight the major issues facing exporters. [ + ]
Funding research into antibiotic resistance
Monash University has been awarded almost $10 million to develop new treatments for life-threatening infections caused by antibiotic-resistant bacteria. [ + ]
Analytica launches $3m capital raising
Analytica (ASX:ALT) is raising up to $3m through a placement and entitlement offer to help accelerate its marketing efforts for female urinary incontinence treatment device PeriCoach. [ + ]
Whooping cough bacterium is evolving
Research led by the University of New South Wales (UNSW) has found that the bacterium that causes whooping cough, Bordetella pertussis, has changed - most likely in response to the vaccine used to prevent the disease. [ + ]
Coastal research centre for China and New Zealand
The University of Waikato has signed an agreement with the Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, to establish a coastal biotechnology research centre. With bases in both Tauranga and China, the China-New Zealand Coastal Biotechnology Joint Research Centre would aim to integrate China and New Zealand's coastal biotechnology research experts. [ + ]
University of Otago and GE Healthcare partner on medical imaging
Medical technology company GE Healthcare has signed a partnership agreement with the University of Otago's Centre for Bioengineering & Nanomedicine to work together on medical imaging technology projects. [ + ]
Algorithm to catch nuclear traffickers
A US research team has discovered that coupling commercially available spectral X-ray detectors with a specialised algorithm can improve the detection of uranium and plutonium in small, layered objects such as baggage. [ + ]
CNS to help plan pancreatic cancer trial
CNS has secured a deal to provide clinical and regulatory services for a Nuvilex pancreatic cancer treatment candidate, including planning for an Australian phase IIb trial. [ + ]
